EMA: Benefits of the AstraZeneca vaccine outweigh risks - blood clots are 'very rare side effects'
Telegraph, 07 Apr 2021
The EU medicine regulator has said that the benefits of the Oxford-AstraZeneca vaccine outweigh the risks of Covid but has said that "unusual blood clots with low blood platelets should be listed as very rare side effects".
For the latest updates, follow our liveblog: https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-covid-vaccine-eu-astrazeneca-lockdown-uk-roadmap/
Subscribe to The Telegraph on YouTube ► https://bit.ly/3idrdLH
Get the latest headlines: https://www.telegraph.co.uk/
Telegraph.co.uk and YouTube.com/TelegraphTV are websites of The Telegraph, the UK's best-selling quality daily newspaper providing news and analysis on UK and world events, business, sport, lifestyle and culture.